Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
D

Failure to Ensure Accurate Medication Documentation and Administration for Anticoagulation Therapy

Fort Walton Beach, Florida Survey Completed on 06-26-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency was identified when the facility failed to ensure that a resident's medical record was clear and accurately documented in accordance with accepted professional standards and practices. The resident, who had recently suffered bilateral femur fractures and was admitted following surgery, was observed with hard braces on both legs and reported pain managed with Tylenol. The resident also stated she had been diagnosed with bilateral Deep Vein Thrombosis (DVT) and was taking Eliquis, an anticoagulant, for this condition. Review of her medical record confirmed the DVT diagnosis and documented a plan from the orthopedic surgeon to use Lovenox for DVT prophylaxis, with a switch to Eliquis planned once her hemoglobin stabilized. However, progress notes from the nurse practitioner indicated that Lovenox should be continued, and Eliquis should only be started when hemoglobin levels were between 8.5 and 9. Despite these documented plans, the Medication Administration Record showed that the resident was receiving Eliquis and not Lovenox. Nursing staff, upon review, acknowledged the discrepancy between the medication orders and what was being administered. The nurse practitioner confirmed in an interview that the resident should have been on Lovenox until her hemoglobin stabilized, which had not yet occurred according to recent lab results. This inconsistency in documentation and medication administration led to the deficiency cited in the report.

An unhandled error has occurred. Reload 🗙